Information
-
- Price : Free
-
- Language : English
Module 1: Clinical pearls for diagnosing COVID-19 – Identifying early is the Key
Lecture Date: 23 May 2021
Faculty
DR. AMITA NENE
MD, DETRD, FCCP(USA), FCPSConsultant Chest Physician & Sleep Medicine Specialist
- Bombay Hospital & Medical
Research Centre,
Executive member of influenza foundation in India
and south Asian academy of sleep medicine.
DR. R. VIJAI KUMAR
MBBS, MD, DTCDPulmonologist: Hyderabad Chest center,
Recipient of the International Fellowship of American
Association of Respiratory Care (FAARC) 1992,
Recipient Fellowship of American College of Chest Physicians 1998,
Recipient of International Chest Foundation award
(for Asthma Education) from ACCP 2000.
Learning Objectives
- Unending pandemic
- Transmission dynamics of SARS CoV-2
- Varied clinical manifestations
- How to distinguish between Flu and COVID?
- Precautions while examining suspected COVID-19 patient
- Diagnostic tests
i. RT-PCR, Rapid Antigen, Antibody
ii. Radiological – HRCT - Recommendations by Indian bodies (ICMR/State)
- Clinical pearls for diagnosing COVID-19
Module 2: Management of Home Quarantine COVID-19 Patients
Lecture Date: 30 May 2021
Faculty
DR. NEERAJ GUPTA
MD, FIPS, FNCCPFounder President - Ajmer Chest Society
Honourable Member - Governing Body : INDIAN CHEST SOCIETY
Fellow, International Agency for Standards and Ratngs Department of Respiratory Medicine -
Jawaharlal
Nehru
Medical College, Ajmer
Senior Consultant Chest Physician and Interventional Pulmonologist Chairman -
State Task Force, RNTCP,
State
of Rajasthan
DR. RAJESH SWARNAKAR
MBBS, DNB(Chest), DTCD, MNAMS, FCCUSANational Secretary: Indian Chest Society
Director & Chief Consultant Pulmonologist
Department of Respiratory, Critical Care, Sleep Medicine and Interventional
Pulmonology - Getwell
Hospital &
Research Institute, Dhantoli, Nagpur.
Learning Objectives
- Home quarantine patients
i. Symptomatics vs Asymptomatics
ii. Analyze the Risk - Why Antivirals are necessary
i. Herd immunity – Far-fetched in reality!
ii. Transient Antibody response
iii. Prolonged RNA shedding - Early antiviral benefit
i. To curtail clinical course & Transmission
ii. To avoid the progression - Therapeutic options - HCQ & Ivermectin
Role of favipiravir
i. Key profile & pharmacology
ii. Global evidence & Recommendations
iii. Indian Phase 3 results - Recommendations by Indian bodies (ICMR/State)
Module 3: Management of High Risk and Severe Patients
Lecture Date: 06 June 2021
Faculty
DR. DJ CHRISTOPHER
BSc, DTCD, DNB, FICS, FAPSR, FRCP(Glasg), FCCP(USA)
Professor- Department of Pulmonary Medicine,
Christian Medical College, Vellore - 632004.
Immediate Past President, Indian Chest Society.
Course Director, Diploma in Allergy & Asthma(DAA)Member.
COVID Clinical Characterization and Management Research Expert group, WHO.
Member, Respiratory Support Working Group, WHO.
DR. INDRANIL HALDER
MBBS, DCH, MD (Pulmonary Medicine)FCCP, FICP, European Diploma in Adult Respiratory Medicine.
Associate Professor & HOD Department of Pulmonary Medicine,
College of Medicine & JNM Hospital, Kalyani,
West Bengal University of Health Science.
Jagdish Bose National Scholar.
Learning Objectives
- Clinical spectrum of COVID-19
i. Mild, Moderate, Severe and Critical - High risk patients for disease progression
i. Advancing age
ii. Comorbidities
iii. Raised biomarkers - Triage as per the Risk score
- Consequences of progression in High risk patients
i. Cytokine storm
ii. Multiorgan inflammatory damage - Early antiviral benefit
i. To curtail clinical course & Transmission
ii. To avoid the progression - Therapeutic options
i. Non-hospitalized
ii. Hospitalized - Role of monoclonal antibodies
- Managing complications
i. Recommendations by Indian bodies(ICMR/State)
Module 4: Long Haulers of Covid
Lecture Date: 13 June 2021
Faculty
DR. RAJA DHAR
MBBS (Cal), MD (Respiratory Medicine), MRCP (UK),MSc (UK) CCT (Respiratory and General Medicine UK),
FCCP (USA), Diploma in Palliative Care (Newcastle University),
Certificate in Education (Deeside University)
Director & Head of Department - Department of Pulmonology, C K Birla Hospitals.
Chair- Training and Education Initiatives: Indian Chest Society.
Director- Research & Training, National Allergy Asthma Bronchitis Institute.
DR. G. C.KHILNANI
MBBS, MD (Medicine), FCCP(USA), FAMS, FICP, FNCCP, FISDAChairman- PSRI Institute of Pulmonary, Critical care &
Sleep medicine, PSRI Hospital,
New
Delhi.
Formerly Professor & Head of Department- Pulmonary, Critical care &
Sleep Medicine, AIIMS, New Delhi.
Learning Objectives
- Chronic COVID Syndrome
- Which lingering symptoms are common?
i. CCoughing, Chronic fatigue, Body aches, Joint pain, Shortness of breath, - Loss of taste and smell,Difficulty sleeping, Headaches, Brain fog
- Who are at risk of becoming long haulers?
- Long term sequel
i. Lung
ii. Heart
iii. Coagulation
iv. Brain
v. Kidney - Evolving role of Post COVID clinic